Go to deals
Healthcare

Alcidion has completed a fundraising

Alcidion Group Ltd. (ASX:ALC) has raised funds to acquire Silverlink PCS Software Limited.

Alcidion is transforming healthcare with smart, intuitive technology solutions that provide real-time clinical decision support. The group integrates with EMR providers and assists doctors and nurses, covering functions such as streamlining patient journeys, smart analytics to help with clinical decisions, improving patient safety and productivity amongst clinical staff through messaging applications, and data capture and interpretation.

Oaklins’ team in Australia acted as joint underwriter, joint lead manager and joint bookrunner, alongside Canaccord Genuity (Australia) Ltd. The team has supported Alcidion in raising over US$70 million across three transactions, along with assisting shareholders to realize value via on-market trading, over the past three years.

Talk to the deal team

Justin Lewis

Managing Director
Melbourne, Australia
Oaklins Henslow

Scott McInnes

Managing Director
Melbourne, Australia
Oaklins Henslow

Related deals

FRP Advisory Group plc has finalized a successful secondary placing
Financial Services

FRP Advisory Group plc has finalized a successful secondary placing

FRP Advisory Group plc has completed a fundraising. The book was oversubscribed and approximately £20.4 million (US$33 million) of shares were sold by certain directors and partners of FRP to new and existing institutional investors at 128 pence per ordinary share.

Learn more
Leika Medical Equipments Ltd. has been acquired by Angus Capital
Private Equity | Healthcare

Leika Medical Equipments Ltd. has been acquired by Angus Capital

The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.

Learn more
Phen’X Technologies has sold a majority stake to Ciclad
Private Equity | Healthcare | Industrial Machinery & Components

Phen’X Technologies has sold a majority stake to Ciclad

The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.

Learn more